2006
31
Dec
Acomplia Italia - Business Portal 24 (press release)
| Acomplia Italia Business Portal 24 (press release), Germany - Rimonabant is a CB1-Rezeptor blocker. It normalizes the overactivity of the Endocannabinoid of system. Rimonabant should be used only with strong … |
More: continued here